Cardiovascular toxicity evaluation of silica nanoparticles in endothelial cells and zebrafish model

Biomaterials

Volumn 34, Issue 23, 2013, Pages 5853-5862

  Duan, Junchao ^a   Yu, Yongbo ^a   Li, Yang ^b   Yu, Yang ^a   Sun, Zhiwei ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Cardiovascular effects; Endothelium; Nanotoxicity; Silica nanoparticles; Zebrafish

Indexed keywords

CARDIOVASCULAR EFFECTS; ENDOTHELIUM; NANOTOXICITY; SILICA NANOPARTICLES; ZEBRAFISH;

CELL DEATH; ENDOTHELIAL CELLS; NANOSTRUCTURED MATERIALS;

TOXICITY;

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYOCYTE ENHANCER FACTOR 2; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; SILICA NANOPARTICLE; TRANSCRIPTION FACTOR NKX2.5; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; BRADYCARDIA; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR MALFORMATION; CARDIOVASCULAR MORTALITY; CYTOTOXICITY; EMBRYO; ENDOTHELIUM CELL; HEART RATE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NANOTOXICOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ZEBRA FISH;

ACRIDINE ORANGE; ANIMALS; CELL DEATH; EMBRYO, NONMAMMALIAN; HEART; HEART RATE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYDRODYNAMICS; MODELS, ANIMAL; NANOPARTICLES; OXIDATIVE STRESS; PARTICLE SIZE; SILICON DIOXIDE; STATIC ELECTRICITY; SUBCELLULAR FRACTIONS; ZEBRAFISH;

DANIO RERIO;

EID: 84877803195     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.04.032     Document Type: Article

References (62)

1. Service R.F. Nanotoxicology. Nanotechnology grows up. Science 2004, 304:1732-1734.
2. Maynard A.D. Aresearch strategy for addressing risk. Nanotechnology 2006, Woodrow Wilson International Center for Scholars.
3. United States Government Accountability Office report on nanotechnology: nanomaterials are widely used in commerce, but EPA faces challenges in regulating risk. Int J Occup Environ Health 2010, 16:525-539.
4. Qian J., Wang D., Cai F., Zhan Q., Wang Y., He S. Photosensitizer encapsulated organically modified silica nanoparticles for direct two-photon photodynamic therapy and invivo functional imaging. Biomaterials 2012, 33:4851-4860.
5. Li Z., Barnes J.C., Bosoy A., Stoddart J.F., Zink J.I. Mesoporous silica nanoparticles in biomedical applications. Chem Soc Rev 2012, 41:2590-2605.
6. Lee J.E., Lee N., Kim T., Kim J., Hyeon T. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications. Acc Chem Res 2011, 44:893-902.
7. Park M.V., Verharen H.W., Zwart E., Hernandez L.G., van Benthem J., Elsaesser A., et al. Genotoxicity evaluation of amorphous silica nanoparticles of different sizes using the micronucleus and the plasmid lacZ gene mutation assay. Nanotoxicology 2011, 5:168-181.
8. Ray P.C., Yu H., Fu P.P. Toxicity and environmental risks of nanomaterials: challenges and future needs. JEnviron Sci Health C Environ Carcinog Ecotoxicol Rev 2009, 27:1-35.
9. Thomas C.R., George S., Horst A.M., Ji Z., Miller R.J., Peralta-Videa J.R., et al. Nanomaterials in the environment: from materials to high-throughput screening to organisms. ACS Nano 2011, 5:13-20.
10. Brook R.D., Rajagopalan S., Pope C.A., Brook J.R., Bhatnagar A., Diez-Roux A.V., et al. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation 2010, 121:2331-2378.
11. Pope C.A., Burnett R.T., Thurston G.D., Thun M.J., Calle E.E., Krewski D., et al. Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation 2004, 109:71-77.
12. Schneider A., Hampel R., Ibald-Mulli A., Zareba W., Schmidt G., Schneider R., et al. Changes in deceleration capacity of heart rate and heart rate variability induced by ambient air pollution in individuals with coronary artery disease. Part Fibre Toxicol 2010, 7:29.
13. Napierska D., Thomassen L.C., Rabolli V., Lison D., Gonzalez L., Kirsch-Volders M., et al. Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small 2009, 5:846-853.
14. Knol A.B., de Hartog J.J., Boogaard H., Slottje P., van der Sluijs J.P., Lebret E., et al. Expert elicitation on ultrafine particles: likelihood of health effects and causal pathways. Part Fibre Toxicol 2009, 6:19.
15. Kadam S.S., Tiwari S., Bhonde R.R. Simultaneous isolation of vascular endothelial cells and mesenchymal stem cells from the human umbilical cord. InVitro Cell Dev Biol Anim 2009, 45:23-27.
16. Alom-Ruiz S.P., Anilkumar N., Shah A.M. Reactive oxygen species and endothelial activation. Antioxid Redox Signal 2008, 10:1089-1100.
17. Xu F., Sun Y., Chen Y., Li R., Liu C., Zhang C., et al. Endothelial cell apoptosis is responsible for the formation of coronary thrombotic atherosclerotic plaques. Tohoku J Exp Med 2009, 218:25-33.
18. Fako V.E., Furgeson D.Y. Zebrafish as a correlative and predictive model for assessing biomaterial nanotoxicity. Adv Drug Deliv Rev 2009, 61:478-486.
19. Bakkers J. Zebrafish as a model to study cardiac development and human cardiac disease. Cardiovasc Res 2011, 91:279-288.
20. Sun L., Li Y., Liu X., Jin M., Zhang L., Du Z., et al. Cytotoxicity and mitochondrial damage caused by silica nanoparticles. Toxicol InVitro 2011, 25:1619-1629.
21. Hu Y.L., Qi W., Han F., Shao J.Z., Gao J.Q. Toxicity evaluation of biodegradable chitosan nanoparticles using a zebrafish embryo model. Int J Nanomedicine 2011, 6:3351-3359.
22. Hu Z., Zhang J., Zhang Q. Expression pattern and functions of autophagy-related gene atg5 in zebrafish organogenesis. Autophagy 2011, 7:1514-1527.
23. Duan J.C., Yu Y.B., Li Y., Yu Y., Li Y.B., Zhou X.Q., et al. Toxic effect of silica nanoparticles on endothelial cells through DNA damage response via Chk1-dependent G2/M checkpoint. PLoS One 2013, 8:e62087.
24. Jiang J., Oberdörster G., Biswas P. Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies. JNanoparticle Res 2009, 11:77-89.
25. Smith A.M., Duan H., Mohs A.M., Nie S. Bioconjugated quantum dots for invivo molecular and cellular imaging. Adv Drug Deliv Rev 2008, 60:1226-1240.
26. Lu F., Wu S.H., Hung Y., Mou C.Y. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small 2009, 5:1408-1413.
27. Chithrani B.D., Ghazani A.A., Chan W.C. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 2006, 6:662-668.
28. Bauer A.T., Strozyk E.A., Gorzelanny C., Westerhausen C., Desch A., Schneider M.F., et al. Cytotoxicity of silica nanoparticles through exocytosis of von Willebrand factor and necrotic cell death in primary human endothelial cells. Biomaterials 2011, 32:8385-8393.
29. Liu X., Sun J. Endothelial cells dysfunction induced by silica nanoparticles through oxidative stress via JNK/P53 and NF-kappaB pathways. Biomaterials 2010, 31:8198-8209.
30. Tedgui A., Mallat Z. Apoptosis, a major determinant of atherothrombosis. Arch Mal Coeur Vaiss 2003, 96:671-675.
31. Hirase T., Node K. Endothelial dysfunction as a cellular mechanism for vascular failure. Am J Physiol Heart Circ Physiol 2012, 302:H499-H505.
32. Inayat-Hussain S.H., Chan K.M., Rajab N.F., Din L.B., Chow S.C., Kizilors A., et al. Goniothalamin-induced oxidative stress, DNA damage and apoptosis via caspase-2 independent and Bcl-2 independent pathways in Jurkat T-cells. Toxicol Lett 2010, 193:108-114.
33. Zhang Y., Hu L., Yu D., Gao C. Influence of silica particle internalization on adhesion and migration of human dermal fibroblasts. Biomaterials 2010, 31:8465-8474.
34. Choi S.J., Oh J.M., Choy J.H. Toxicological effects of inorganic nanoparticles on human lung cancer A549 cells. JInorg Biochem 2009, 103:463-471.
35. Li Y., Sun L., Jin M., Du Z., Liu X., Guo C., et al. Size-dependent cytotoxicity of amorphous silica nanoparticles in human hepatoma HepG2 cells. Toxicol InVitro 2011, 25:1343-1352.
36. Heitzer T., Schlinzig T., Krohn K., Meinertz T., Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001, 104:2673-2678.
37. Corbalan J.J., Medina C., Jacoby A., Malinski T., Radomski M.W. Amorphous silica nanoparticles trigger nitric oxide/peroxynitrite imbalance in human endothelial cells: inflammatory and cytotoxic effects. Int J Nanomedicine 2011, 6:2821-2835.
38. Fichtlscherer S., Breuer S., Zeiher A.M. Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: further evidence for the existence of the "vulnerable" patient. Circulation 2004, 110:1926-1932.
39. Schachinger V., Britten M.B., Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000, 101:1899-1906.
40. Yan H., Teh C., Sreejith S., Zhu L., Kwok A., Fang W., et al. Functional mesoporous silica nanoparticles for photothermal-controlled drug delivery invivo. Angew Chem Int Ed Engl 2012, 51:8373-8377.
41. Bar-Ilan O., Louis K.M., Yang S.P., Pedersen J.A., Hamers R.J., Peterson R.E., et al. Titanium dioxide nanoparticles produce phototoxicity in the developing zebrafish. Nanotoxicology 2012, 6:670-679.
42. Zhu X., Zhu L., Duan Z., Qi R., Li Y., Lang Y. Comparative toxicity of several metal oxide nanoparticle aqueous suspensions to Zebrafish (Danio rerio) early developmental stage. JEnviron Sci Health Part A 2008, 43:278-284.
43. Lee K.J., Nallathamby P.D., Browning L.M., Desai T., Cherukuri P.K., Xu X.H. Single nanoparticle spectroscopy for real-time invivo quantitative analysis of transport and toxicity of single nanoparticles in single embryos. Analyst 2012, 137:2973-2986.
44. Xu Z., Zhang Y.L., Song C., Wu L.L., Gao H.W. Interactions of hydroxyapatite with proteins and its toxicological effect to zebrafish embryos development. PLoS One 2012, 7:e32818.
45. Lee K.J., Browning L.M., Nallathamby P.D., Desai T., Cherukuri P.K., Xu X.H. Invivo quantitative study of sized-dependent transport and toxicity of single silver nanoparticles using zebrafish embryos. Chem Res Toxicol 2012, 25:1029-1046.
46. Usenko C.Y., Harper S.L., Tanguay R.L. Invivo evaluation of carbon fullerene toxicity using embryonic zebrafish. Carbon N Y 2007, 45:1891-1898.
47. Verkerk A.O., Remme C.A. Zebrafish: a novel research tool for cardiac (patho)electrophysiology and ion channel disorders. Front Physiol 2012, 3:255.
48. Hecker L., Khait L., Sessions S.K., Birla R.K. Functional evaluation of isolated zebrafish hearts. Zebrafish 2008, 5:319-322.
49. King-Heiden T.C., Wiecinski P.N., Mangham A.N., Metz K.M., Nesbit D., Pedersen J.A., et al. Quantum dot nanotoxicity assessment using the zebrafish embryo. Environ Sci Technol 2009, 43:1605-1611.
50. Pratheeshkumar P., Son Y.O., Budhraja A., Wang X., Ding S., Wang L., et al. Luteolin inhibits human prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis. PLoS One 2012, 7:e52279.
51. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat Med 2003, 9:669-676.
52. Cho C.H., Lee C.S., Chang M., Jang I.H., Kim S.J., Hwang I., et al. Localization of VEGFR-2 and PLD2 in endothelial caveolae is involved in VEGF-induced phosphorylation of MEK and ERK. Am J Physiol Heart Circ Physiol 2004, 286:H1881-H1888.
53. Hinits Y., Pan L., Walker C., Dowd J., Moens C.B., Hughes S.M. Zebrafish Mef2ca and Mef2cb are essential for both first and second heart field cardiomyocyte differentiation. Dev Biol 2012, 369:199-210.
54. Ghosh T.K., Song F.F., Packham E.A., Buxton S., Robinson T.E., Ronksley J., et al. Physical interaction between TBX5 and MEF2C is required for early heart development. Mol Cell Biol 2009, 29:2205-2218.
55. Illi B., Scopece A., Nanni S., Farsetti A., Morgante L., Biglioli P., et al. Epigenetic histone modification and cardiovascular lineage programming in mouse embryonic stem cells exposed to laminar shear stress. Circ Res 2005, 96:501-508.
56. Lin Q., Schwarz J., Bucana C., Olson E.N. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 1997, 276:1404-1407.
57. Targoff K.L., Schell T., Yelon D. Nkx genes regulate heart tube extension and exert differential effects on ventricular and atrial cell number. Dev Biol 2008, 322:314-321.
58. Jay P.Y., Berul C.I., Tanaka M., Ishii M., Kurachi Y., Izumo S. Cardiac conduction and arrhythmia: insights from Nkx2.5 mutations in mouse and humans. Novartis Found Symp 2003, 250:227-238.
59. Blaschke R.J., Hahurij N.D., Kuijper S., Just S., Wisse L.J., Deissler K., et al. Targeted mutation reveals essential functions of the homeodomain transcription factor Shox2 in sinoatrial and pacemaking development. Circulation 2007, 115:1830-1838.
60. Schott J.J., Benson D.W., Basson C.T., Pease W., Silberbach G.M., Moak J.P., et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 1998, 281:108-111.
61. Patra C.R., Kim J.H., Pramanik K., d'Uscio L.V., Patra S., Pal K., et al. Reactive oxygen species driven angiogenesis by inorganic nanorods. Nano Lett 2011, 11:4932-4938.
62. Yusuf S., Reddy S., Ôunpuu S., Anand S. Global burden of cardiovascular diseases. Circulation 2001, 104:2855-2864.